Rankings
▼
Calendar
CRON FY 2024 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$118M
+34.8% YoY
Gross Profit
$25M
21.4% margin
Operating Income
-$77M
-65.1% margin
Net Income
$41M
34.9% margin
EPS (Diluted)
$0.11
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
$6M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$55M
Stockholders' Equity
$1.1B
Cash & Equivalents
$859M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$118M
$87M
+34.8%
Gross Profit
$25M
$12M
+111.6%
Operating Income
-$77M
-$85M
+9.8%
Net Income
$41M
-$74M
+155.5%
← Q4 2023
All Quarters
Q1 2024 →